Miromatrix Medical Inc.
DelistedCIK 1527096fmd_0DMJ995NN14RA7WHJ503AZA6BAManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2020 to Sep 30, 2023, 15 periods
Latest annual · FY2022
Millions- Total revenues
- 1
- Gross profit
- 0
- Operating income
- (30)
- Net income
- (30)
- Free cash flow
- (28)
Latest quarter · Q3 FY2023
Millions- Total revenues
- 0
- Gross profit
- (0)
- Operating income
- (7)
- Net income
- (6)
- Free cash flow
- (5)
Miromatrix Medical Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $953,470 | 10-K 2023-03-31 · proof | ||
| Gross profit | $453,470 | -$466,934 | 10-K 2023-03-31 · proof | |
| Operating income | -$30.4 million | -$17 million | 10-K 2023-03-31 · proof | |
| Net income | -$30 million | -$14.7 million | 10-K 2023-03-31 · proof | |
| Cash from operating activities | -$26.7 million | -$14.8 million | 10-K 2023-03-31 · proof | |
| Free cash flow | -$27.7 million | -$18.2 million | 10-K 2023-03-31 · proof | |
| Total assets | $34.8 million | $60.9 million | -42.9% | 10-K 2023-03-31 · proof |
| Total liabilities | $8.7 million | $6.8 million | +27.2% | 10-K 2023-03-31 · proof |
| Cash and cash equivalents | $5.2 million | $52.8 million | -90.1% | 10-K 2023-03-31 · proof |
- What was Miromatrix Medical Inc.'s revenue in fiscal 2022?
- Miromatrix Medical Inc. reported revenue of $953,470 for fiscal 2022 (the year ended Dec 31, 2022). Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What was Miromatrix Medical Inc.'s gross profit in fiscal 2022?
- Miromatrix Medical Inc. reported gross profit of $453,470 for fiscal 2022 (the year ended Dec 31, 2022), against -$466,934 the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What was Miromatrix Medical Inc.'s operating income in fiscal 2022?
- Miromatrix Medical Inc. reported operating income of -$30.4 million for fiscal 2022 (the year ended Dec 31, 2022), against -$17 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What was Miromatrix Medical Inc.'s net income in fiscal 2022?
- Miromatrix Medical Inc. reported net income of -$30 million for fiscal 2022 (the year ended Dec 31, 2022), against -$14.7 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What was Miromatrix Medical Inc.'s cash from operating activities in fiscal 2022?
- Miromatrix Medical Inc. reported cash from operating activities of -$26.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$14.8 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What was Miromatrix Medical Inc.'s free cash flow in fiscal 2022?
- Miromatrix Medical Inc. reported free cash flow of -$27.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$18.2 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What are Miromatrix Medical Inc.'s total assets?
- As of Dec 31, 2022, Miromatrix Medical Inc. reported total assets of $34.8 million, against $60.9 million a year earlier (-42.9%). Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What are Miromatrix Medical Inc.'s total liabilities?
- As of Dec 31, 2022, Miromatrix Medical Inc. reported total liabilities of $8.7 million, against $6.8 million a year earlier (+27.2%). Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
- What are Miromatrix Medical Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Miromatrix Medical Inc. reported cash and cash equivalents of $5.2 million, against $52.8 million a year earlier (-90.1%). Source: the 10-K filed with the SEC on Mar 31, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1527096&period_type=annual&limit=5"Information only, not investment advice.